Category: Research Administration

NIH has issued a notice requesting input by July 28 on potential revisions to reduce administrative burdens or costs related to compliance with OMB Circular A-21, Cost Principles for Educational Institutions. For more details, read this recent blog post from NIH’s Sally Rockey.

There is now a shortened review cycle for applications from new investigators. To give these applicants more time to prepare resubmissions (A1) between review cycles, NIH will accelerate the release of summary statements for the initial applications (A0). It has also pushed back the special submission date for new investigators to give them at least 30 days to prepare the revised application. Please refer to NOT-OD-11-057 for more details.

While we’re on this topic, I’d like to clear up confusion about when to submit a new application versus a resubmission. New applications and resubmissions typically differ in several important aspects (due date, introduction, etc.). For most funding opportunity announcements (FOAs), deciding whether to prepare a new submission (A0) or a resubmission (A1) is straightforward. But sometimes it’s not!

Here’s a little clarification. All applications in response to a request for applications (RFA) are considered new, unless the RFA says that applications to previous versions of the RFA may be submitted as resubmissions. For example, if NIGMS has issued an RFA and then decides to continue it via a non-RFA FOA, all applications to the FOA must be new the first time they are submitted. Similarly, if a PI continues an awarded U series application as an R series application (e.g., U01 to R01 after the original U01 FOA expired), then the R series application must be new.

Finally, applications to continue work started in a special Recovery Act activity code (RC1, RC2, RC3, RC4, etc.) should be submitted as new applications. Recovery Act competitive revision (S1) applications that were submitted to an existing FOA are an exception. They must be submitted as resubmissions (S1A1) and are subject to the NIH resubmission limit policy.

For those of you interested in a broader discussion of resubmissions, see the “Early Data on the A2 Sunset” blog post from OER director Sally Rockey.

NIH has issued a notice with important reminders affecting grant applications submitted on or after January 25.

The NIH policy on page limits means that reviewers need not consider text or materials that have been inappropriately placed in the Appendix or other sections without page limits, particularly when they circumvent page limitations for the Specific Aims and Research Strategy sections. In some instances, NIH may withdraw the application from review or funding consideration. For a reminder of what’s acceptable in the Appendix, see NOT-OD-10-077.

Also, post-submission application materials must adhere to new restrictions on timing and content; see NOT-OD-10-091.

As I previously posted on August 20 and October 8, other application policy changes also on the way for submissions on or after January 25 include:

1. Elimination of the error correction window from the application process for electronic and paper-based submissions; see NOT-OD-10-123.
2. Resubmission deadlines of no more than 37 months after the receipt date of the initial application; see NOT-OD-10-140.
3. New application forms for F, K, T and D series applications, which will apply to all other applications as of May 7, 2011; see NOT-OD-11-007 and NOT-OD-11-008.

Here are several new NIH Guide notices regarding applications:

New Time Limit for NIH Resubmission Applications
Revised applications must be submitted no later than 37 months after submission of the preceding version. In most cases, the clock will start at the original receipt date. For special cases, please refer to NOT-OD-10-140.

NIH to Require Use of Updated Electronic Application Forms in 2011
Submissions for deadlines after May 7, 2011, must use an updated forms package (ADOBE-FORMS-B1). For deadlines before then, applicants may use either the new forms package or the current one, ADOBE-FORMS-B. There are some exceptions: K, T, D or F series applications submitted for deadlines on or after January 25, 2011, must use the new forms package. For more information, see NOT-OD-11-008 and NOT-OD-11-007.

NIH has rescinded the earlier notice regarding the status of applications and grants involving human embryonic stem cells. The new notice states that the receipt, processing, review and awarding of NIH applications and proposals involving human embryonic stem cells will continue. It goes on to list the following actions:

• The suspension of further NIH activity to implement, apply or act pursuant to the NIH Guidelines is hereby lifted.
• The suspension of the issuance of all pending competing, and noncompeting continuation hESC awards and contracts approved for funding is hereby lifted.
• The suspension of the peer review of all pending competing hESC applications and proposals is hereby lifted.
• The NIH Human Embryonic Stem Cell Registry will resume accepting submissions of information about hESC lines for the purpose of establishing eligibility for funding under the NIH Guidelines. The NIH review of hESC lines for inclusion on the Registry under the NIH Guidelines will also resume.

NIH has issued a notice describing the status of applications and grants that propose research using human embryonic stem cells (hESC). Among its points are:

• Any further NIH activity to implement, apply or act pursuant to the NIH Guidelines is hereby suspended until further notice.
• Issuance of all pending competing, and noncompeting continuation hESC awards and contracts is suspended until further notice.
• The peer review of all pending competing hESC applications and proposals is suspended until further notice.

Grants affected include all types of research and training. We expect more guidance soon and will let you know when it’s posted.